Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

Abstract Introduction The validated 40-gene expression profile (40-GEP) test independently stratifies risk of regional or distant metastasis for cutaneous squamous cell carcinoma (cSCC) tumors with high-risk clinicopathologic features. This study evaluated the stratification of risk by the 40-GEP te...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ashley Wysong, Ally‐Khan Somani, Sherrif F. Ibrahim, Javier Cañueto, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Christie Regula, Anna Bar, Julia Kasprzak, David G. Brodland, Shlomo A. Koyfman, Sarah T. Arron
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Adis, Springer Healthcare 2024-03-01
Schriftenreihe:	Dermatology and Therapy
Schlagworte:	40-GEP Cutaneous squamous cell carcinoma Metastasis Prognostic Risk assessment
Online-Zugang:	https://doi.org/10.1007/s13555-024-01111-5
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!